InsidersTradesSigma
SynAct Pharma AB: insider trades · Finland · FIN-FSA
FI:synact-pharma-ab-fb8e62SE0008241491FI·FIN-FSAMcap 791M€Healthcare
Discover the full directors' dealings record of SynAct Pharma AB, a listed equity based in Finland. Shares are quoted on FI FI, under the supervision of FIN-FSA. Operating in the Healthcare sector, SynAct Pharma AB has recorded 1 insider filings. Market capitalisation: €790.7m. The latest transaction was reported on 9 March 2026 — Purchase. Among the most active insiders: Mads Liebach Bjerregaard. All data is openly available.
1
Insider Decl.
0
Thresholds
€2,517
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
14.12 €
Analyst consensus
2 analystsStrong buy
30.00 €Target 34.65 €(+145%)39.30 €
Income statement
Net income−110.8 M€0.0% margin
Valuation
PER (forward)-18.6x
P/Book4.4x
Beta0.88
Balance sheet & cash
Market cap790.7 M€
Total debt1.2 M€
Free Cash Flow−97.3 M€
Debt / Equity1%
Profitability & ownership
ROE-57.7%
ROA-29.6%
% insiders29.9%
% institutions19.4%
Last declaration on 9 March 2026
Declarations1 total
Executives●Purchase20FIN-FSA
€2,5171,500 shares@ €1.6780.0003% mcap100.0% of flow
Aktie
FI:A003W835-1·
Ideal exit: 30 Nov 2026 (T+270)
1 of 1 declaration